Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
10.02% FM, SH, AS----1件: 53 💬
21500MG mesalazine pellets
(Asacol)		1件: Mesalazine (5-ASA)1件: Mesalamine (Asacol) 💬 --1件: 97 💬
3250MG mesalazine pellets
(Asacol)		1件: Mesalazine (5-ASA)1件: Mesalamine (Asacol) 💬 --1件: 97 💬
42L polyethylene glycol/ascorbic acid----1件: 97 💬
55 ASA, enemas, suppositories, corticosteroids----1件: 97 💬
65-aminosalicylic acid(5-ASA) and/or prednisone1件: Mesalazine (5-ASA)1件: Mesalamine (Asacol) 💬 --1件: 97 💬
75-ASA1件: Mesalazine (5-ASA)1件: Mesalamine (Asacol) 💬 --1件: 97 💬
85-ASA MMX1件: Mesalazine (5-ASA)1件: Mesalamine (Asacol) 💬 --1件: 97 💬
9500MG mesalazine pellets
(Asacol)		1件: Mesalazine (5-ASA)1件: Mesalamine (Asacol) 💬 --1件: 97 💬
10750MG mesalazine pellets
(Asacol)		1件: Mesalazine (5-ASA)1件: Mesalamine (Asacol) 💬 --1件: 97 💬
1181MG aspirin----1件: 49 💬
12A novel synthetic, orally-administered, NON-peptide small molecule, which acts AS----1件: 254 💬
13Aavrh.10hfxn, serotype RH.10 adeno-associated virus (AAV) gene transfer vector expressing THE cdna coding FOR human FXN----1件: 18 💬
14Abatacept also known AS orencia also known AS CTLA4-IG1件: Abatacept1件: Abatacept 💬 2件: CD80,
CD86 💬 		13件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬1件: 49 💬
15Accelerometry TO assess physical activity----1件: 299 💬
16Acetylsalicylic acid
(Aspirin, Aspalon)		1件: Acetylsalicylic acid (Aspirin)1件: Aspirin (Aspirin, Aspalon) 💬 2件: PTGS1,
PTGS2 💬 		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬4件: 13, 46, 51, 210 💬
17Acido ascorbico----1件: 10 💬
18Acidum ascorbicum D61件: Ascorbic acid (Ascorbate)1件: Ascorbic acid (Ascorbic acid, Ascoltin, Ascorbicap, ASCOR, ASCOR) 💬 --1件: 206 💬
19ACR16 hydrochloride, ASP2314 hydrochloride, FR310826----1件: 8 💬
20Adeno-associated viral (AAV) serotype 8 (AAV2/8) vector with liver-specific thyroxine-binding globulin (TBG) promoter, driving THE expression OF THE human arsb gene----1件: 19 💬
21Adeno-associated viral vector serotype 3B encoding shortened human ATP7B----1件: 171 💬
22Adeno-associated viral vector serotype 8 containing THE human MD1 gene----1件: 113 💬
23Adeno-associated viral vector serotype 9 containing THE human MINI-dystrophin gene----1件: 113 💬
24Adeno-associated viral vector serotype 9 containing THE human N-acetyl-alpha-glucosaminidase gene----1件: 19 💬
25Adeno-associated viral vector serotype 9 encoding human ATP7B----1件: 171 💬
26Adeno-associated viral vector serotype 9 expressing codon-optimized human GRN gene----1件: 127 💬
27Adeno-associated viral vector serotype RH10 containing THE human cholesterol 24-hydroxylase gene----1件: 8 💬
28Adeno-associated virus serotype 2/6 encoding human alpha-galactosidase A cdna----1件: 19 💬
29Adeno-associated virus serotype 2/6 encoding human iduronate 2-sulfatase (hids) gene donor vector, SB-A6P-HNT donor vector----1件: 19 💬
30Adeno-associated virus serotype 2/6 encoding left SIDE-zinc finger nuclease (ZFN1), SB-A6P-zleft vector----1件: 19 💬
31Adeno-associated virus serotype 2/6 encoding right SIDE-zinc finger nuclease (ZFN2), SB-A6P-zright vector----1件: 19 💬
32Adeno-associated virus serotype 5 encoding A microrna targeted TO human huntingtin gene----1件: 8 💬
33Adeno-associated virus serotype 9 carrying THE human fukutin-related protein and target sequence OF THE MIR-208A----1件: 113 💬
34Adeno-associated virus serotype HU68 containing THE human galc gene----1件: 19 💬
35Adeno-associated virus serotype RH.10 expressing BETA-galactosidase----1件: 19 💬
36Adeno-associated virus serotype RH74 containing THE human delandistrogene moxeparvovec dystrophin gene1件: Delandistrogene moxeparvovec1件: Delandistrogene moxeparvovec 💬 1件: DMD 💬 5件: Arrhythmogenic right ventricular cardiomyopathy, Cytoskeleton in muscle cells, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Viral myocarditis 💬1件: 113 💬
37Adeno-associated virus serotype RH74 containing THE human micro- dystrophin gene----1件: 113 💬
38Adeno-associated virus serotype RH74 containing THE human micro-dystrophin gene----1件: 113 💬
39Adeno-associated virus type 2 vector encoding RAB escort protein 1----1件: 90 💬
40Adeno-associated virus-cftr vector----1件: 299 💬
41Alginic acid
(Ascophyllum)		1件: Alginic acid2件: Alginic acid ,
Sodium alginate (Ascophyllum) 💬 		--1件: 51 💬
42ALLO-ASC----1件: 96 💬
43ALLO-ASC-CD----1件: 96 💬
44ALLO-ASC-DFU----1件: 36 💬
45ALLO-ASC-sheet----1件: 36 💬
46ALN-AS1----1件: 254 💬
47Also referred TO AS 'MEDI2070'----1件: 97 💬
48Also referred TO AS MED2070----1件: 96 💬
49Also referred TO AS MEDI2070----2件: 96, 97 💬
50Amoxapine & dipyridamole
(Asendin)		1件: Amoxapine1件: Amoxapine (Asendin) 💬 2件: SLC6A2,
SLC6A4 💬 		3件: Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬1件: 46 💬
51Amyl nitrite inhalation
(Aspiral)		1件: Amyl Nitrite1件: Amyl nitrite (Aspiral) 💬 3件: GUCY1A,
GUCY1A,
GUCY1B 💬 		10件: Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 58 💬
52AS2----1件: 6 💬
53ASA----1件: 13 💬
54Asacol1件: Mesalazine (5-ASA)1件: Mesalamine (Asacol) 💬 --1件: 97 💬
55Asacol (mesalamine) delayed-release tablets1件: Mesalazine (5-ASA)1件: Mesalamine (Asacol) 💬 --1件: 97 💬
56Asacol 400 MG1件: Mesalazine (5-ASA)1件: Mesalamine (Asacol) 💬 --1件: 97 💬
57Asacol 400 MG tablet1件: Mesalazine (5-ASA)1件: Mesalamine (Asacol) 💬 --1件: 97 💬
58Asacol 400MG tablet1件: Mesalazine (5-ASA)1件: Mesalamine (Asacol) 💬 --1件: 97 💬
59Asacol 800 MG tablet1件: Mesalazine (5-ASA)1件: Mesalamine (Asacol) 💬 --1件: 97 💬
60Asacol 800MG tablet1件: Mesalazine (5-ASA)1件: Mesalamine (Asacol) 💬 --1件: 97 💬
61Asacol delayed release tablets1件: Mesalazine (5-ASA)1件: Mesalamine (Asacol) 💬 --1件: 97 💬
62Asacol delayed-release tablets1件: Mesalazine (5-ASA)1件: Mesalamine (Asacol) 💬 --1件: 97 💬
63Asacol® 400 MG----1件: 97 💬
64Asasantin retard----1件: 51 💬
65ASB-683699----1件: 13 💬
66ASC----1件: 97 💬
67ASC42 10 MG----1件: 93 💬
68ASC42 15 MG----1件: 93 💬
69ASC42 5 MG----1件: 93 💬
70Ascal(R) / carbasalate calcium----1件: 46 💬
71Asclera----1件: 34 💬
72Ascorbic acid1件: Ascorbic acid (Ascorbate)1件: Ascorbic acid (Ascorbic acid, Ascoltin, Ascorbicap, ASCOR, ASCOR) 💬 --4件: 10, 97, 206, 298 💬
73Ascs----2件: 53, 97 💬
74Ascs: adipose derived stem cells----1件: 96 💬
75Ascs:adipose derived stem cells----1件: 97 💬
76Asendis 50 MG----1件: 46 💬
77Asfotas alfa----1件: 172 💬
78Asfotase alfa1件: Asfotase alfa (Asfotase alfa)1件: Asfotase alfa (Asfotase alfa, Asfotase alfa) 💬 1件: E3.1.3.1 💬 2件: Folate biosynthesis, Thiamine metabolism 💬1件: 172 💬
79ASK NR. 21972----1件: 5 💬
80ASK8007----1件: 46 💬
81ASP015K----2件: 46, 97 💬
82ASP015K hydrobromide, AS1940150-BR, JKT-201A, 4-{[(1R,2S,3S,5S,7S)-5-hydroxy-2-adamantyl]amino}-1H-pyrrolo[2,3-B]pyridine-5-carboxamide monohydrobromide----1件: 46 💬
83ASP1707----1件: 46 💬
84ASP2016----1件: 18 💬
85ASP2408----1件: 46 💬
86ASP2409----1件: 46 💬
87ASP3291----1件: 97 💬
88ASP3652----1件: 226 💬
89ASP5094----1件: 46 💬
90ASP5502----1件: 53 💬
91ASP6294----1件: 226 💬
92Aspaveli1件: Pegcetacoplan1件: Pegcetacoplan 💬 1件: C3 💬 17件: Alcoholic liver disease, Chagas disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Phagosome, Shigellosis, Staphylococcus aureus infection, Systemic lupus erythematosus, Tuberculosis, Viral carcinogenesis 💬4件: 2, 61, 62, 222 💬
93Aspergillus oryzae1件: Aspergillus oryzae (Aspergillus oryzae)---1件: 97 💬
94Aspirin1件: Acetylsalicylic acid (Aspirin)1件: Aspirin (Aspirin, Aspalon) 💬 2件: PTGS1,
PTGS2 💬 		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬12件: 13, 22, 34, 46, 49, 51, 86, 113, 158, 210, 231, 271 💬
95Aspirin 650MG oral capsule1件: Acetylsalicylic acid (Aspirin)1件: Aspirin (Aspirin, Aspalon) 💬 2件: PTGS1,
PTGS2 💬 		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 13 💬
96Aspirin 81MG EC TAB1件: Acetylsalicylic acid (Aspirin)1件: Aspirin (Aspirin, Aspalon) 💬 2件: PTGS1,
PTGS2 💬 		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬2件: 96, 97 💬
97Aspirin 81MG tablet1件: Acetylsalicylic acid (Aspirin)1件: Aspirin (Aspirin, Aspalon) 💬 2件: PTGS1,
PTGS2 💬 		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 46 💬
98Aspirin and meloxicam1件: Acetylsalicylic acid (Aspirin)1件: Aspirin (Aspirin, Aspalon) 💬 2件: PTGS1,
PTGS2 💬 		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 49 💬
99Aspirin tablet1件: Acetylsalicylic acid (Aspirin)1件: Aspirin (Aspirin, Aspalon) 💬 2件: PTGS1,
PTGS2 💬 		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 64 💬
100Aspirin tablets1件: Acetylsalicylic acid (Aspirin)1件: Aspirin (Aspirin, Aspalon) 💬 2件: PTGS1,
PTGS2 💬 		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 46 💬
101Assessment during THE transition between OFF-levodopa (I.E. withdrawal OF levodopa phase) and ON-levodopa (I.E. effect OF levodopa phase)states----1件: 6 💬
102Assessment OF activity and muscle fatigue----1件: 3 💬
103Assessment OF arterial stiffness using THE vasera VS-1500N----2件: 89, 299 💬
104Assessment OF biological factors----1件: 97 💬
105Assessment OF bulbar function----1件: 3 💬
106Assessment OF cognition----1件: 6 💬
107Assessment OF depression----1件: 6 💬
108Assessment OF disability----1件: 13 💬
109Assessment OF genetics----1件: 97 💬
110Assessment OF impact OF MS ON cognition----1件: 13 💬
111Assessment OF medication compliance----1件: 98 💬
112Assessment OF motor and NON-motors symptoms OF PD evaluation OF hyper- and hypodopaminergic behaviors----1件: 6 💬
113Assessment OF psychophysiological factors----1件: 97 💬
114Assessment OF quality OF life----2件: 6, 97 💬
115Assessment OF severity OF parkinson disease----1件: 6 💬
116Assessment OF therapy complications----1件: 60 💬
117Assessments IN ON and OFF levodopa state----1件: 6 💬
118Assigned interventions CD19/bcma CAR T-cells----3件: 49, 51, 53 💬
119Assigned pulmonary hypertension medication----1件: 86 💬
120AST-120----2件: 96, 97 💬
121Astaxanthin1件: Astaxanthin (Astaxanthin)---1件: 2 💬
122Asthma patients----1件: 299 💬
123Astrorx----1件: 2 💬
124Asyn MAB----1件: 6 💬
125Audiology assessment with ABR----1件: 19 💬
126Autologous ASC----1件: 51 💬
127Azathioprine or mesalazine
(Asacol)		1件: Azathioprine2件: Azathioprine ,
Azathioprine sodium 💬 		--1件: 96 💬
128Azatioprina aspen - 50 compresse1件: Azathioprine2件: Azathioprine ,
Azathioprine sodium 💬 		--1件: 96 💬
129B2-asmedic----1件: 97 💬
130Belantamab mafodotin every 4 weeks, 6 weeks,8 weeks, or 12 weeks AS determined BY part 1 recommended dosages1件: Belantamab mafodotin1件: Belantamab mafodotin 💬 10件: TNFRSF17,
TUBB,
TUBB,
TUBB,
TUBB,
TUBB,
TUBB,
TUBB,
TUBB,
TUBB 💬 		13件: Alzheimer disease, Amyotrophic lateral sclerosis, Cytokine-cytokine receptor interaction, Gap junction, Huntington disease, Intestinal immune network for IgA production, Motor proteins, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬1件: 28 💬
131Betamethasone solution AS intramuscular injection period 1 and period 21件: Betamethasone6件: Betamethasone ,
Betamethasone sodium phosphate ,
Betamethasone valerate ,
Betamethasone acetate ,
Betamethasone dipropionate ,
Betamethasone benzoate 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 65 💬
132Biological assays----1件: 19 💬
133Biological assessment----1件: 61 💬
134Blood assays----1件: 113 💬
135Blood draw FOR THE laboratory assessment----2件: 94, 303 💬
136Blood tests: IGF-1, AST/ALT/ALP/tbil, GTT----1件: 77 💬
137Bone marrow aspirate----1件: 60 💬
138Bone marrow aspiration----8件: 2, 28, 60, 62, 65, 284, 285, 286 💬
139Bone marrow aspiration and biopsy----3件: 28, 34, 60 💬
140Busulfan/fludarabine phosphate/tacrolimus/methotrexate/G-CSF
(ASTAGRAF XL)		1件: Busulfan1件: Busulfan 💬 --1件: 60 💬
141Carbidopa/levodopa, AS prescribed BY treating physician1件: Carbidopa1件: Carbidopa 💬 1件: DDC 💬 8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
142Care AS usual----1件: 15 💬
143CBD - oral solution, IS known AS epidyolex, and IS THE approved name1件: Cannabidiol1件: Cannabidiol 💬 2件: CNR1,
CNR2 💬 		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 156 💬
144CBD oral solution, IS known AS epidyolex and IS THE approved name IN THE EU1件: Cannabidiol1件: Cannabidiol 💬 2件: CNR1,
CNR2 💬 		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 156 💬
145CELL-based EX-vivo assay with HIGH-content analysis----1件: 41 💬
146CERE-120: adeno-associated virus delivery OF neurturin1件: CERE-120---1件: 6 💬
147Childhood health assessment questionnaire----1件: 50 💬
148Clinical and neuropsychological assessments----1件: 6 💬
149Clinical assessment----2件: 6, 13 💬
150Combination OF navepegritide and lonapegsomatropin administered AS TWO separate S.C. injections----1件: 276 💬
151Computer-assisted telephone interview----1件: 85 💬
152Control group: mesalazine enema treatment
(Asacol)		----1件: 97 💬
153Covid-19 vaccine astrazeneca1件: AstraZeneca COVID-19 Vaccine (AstraZeneca COVID-19 Vaccine)---2件: 46, 51 💬
154Cyclin D1 gene (CCDN1) /immunoglobulin heavy chain (IGH) fluorescence IN situ hybridization (fish) assay----1件: 28 💬
155Cyclo ((diaminoethyl-carbamate)hypro-PHG-(D) TRP-LY DI-aspartate----1件: 75 💬
156Cyclo ((diaminoethyl-carbamate)hypro-PHG-(D)TRP-LY DI-aspartate----1件: 75 💬
157Cyclo((diaminoethyl-carbamate)hypro-PHG-(D)TRP-LYS-TYR(BZL)-PHE) DI-aspartate----1件: 75 💬
158D-aspartate----1件: 13 💬
159Delayed and extended release mesalazine
(Asacol)		----1件: 97 💬
160Dietary assignment----1件: 95 💬
161Dipyridamole and amoxapine
(Asendin)		1件: Dipyridamole1件: Dipyridamole 💬 2件: PDE4,
PDE5 💬 		5件: Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 46 💬
162Direct puncture repair / polidocanol
(Asclera, ASCLERA)		----1件: 279 💬
163Doxorubicin, methotrexate, cyclophosphamide, L-asparaginase1件: Doxorubicin2件: Doxorubicin hydrochloride ,
Doxorubicin 💬 		--1件: 65 💬
164Eating assessment tool 10----1件: 2 💬
165Eating assessment TOOL-10----1件: 2 💬
166Egcg AS putative neuroprotective agent1件: Epigallocatechin gallate---1件: 17 💬
167END-OF-life nursing education consortium-pediatric palliative care AS WEB based-training plus usual care----2件: 113, 299 💬
168Enzyme-linked immunosorbent assay----1件: 41 💬
169Epinephrine
(Asmatane mist)		1件: Epinephrine3件: Epinephrine ,
Epinephrine hydrochloride ,
Epinephrine bitartrate (Asmatane mist) 💬 		9件: ADRA1A,
ADRA1B,
ADRA1D,
ADRA2A,
ADRA2B,
ADRA2C,
ADRB1,
ADRB2,
ADRB3 💬 		16件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 46 💬
170ERA AS specific PAH treatment----1件: 86 💬
171Evaluation OF THE parameters OF THE lithiasis assessment before and after kaftrio initiation----1件: 299 💬
172Exhaled nitric oxide assessment----1件: 46 💬
173Extended release dipyridamole 200MG/aspirin 25MG----1件: 49 💬
174Fazirsiran (TAK-999, also referred TO AS ARO-AAT) injection1件: Fazirsiran---1件: 231 💬
175First-line cognitive assessment----1件: 3 💬
176Fish assay----1件: 28 💬
177Fludrocortisone
(Astonin-H)		1件: Fludrocortisone2件: Fludrocortisone acetate ,
Fludrocortisone (Astonin-H) 💬 		1件: NR3C2 💬 1件: Aldosterone-regulated sodium reabsorption 💬3件: 6, 17, 81 💬
178Full history , clinical examination, assesment OF disease activity ,laboratory investigations ( CBC , ESR, CRP serum creatinine and blood urea, random plas----2件: 46, 49 💬
179Functional assessment questionnaires----1件: 41 💬
180GC101 adeno-associated virus injection----1件: 3 💬
181Gelatin
(Ass hide glue, Asini corii collas)		1件: Gelatin2件: Gelatin ,
Donkey glue (Ass hide glue, Asini corii collas) 💬 		--3件: 47, 62, 70 💬
182Glucocorticoid + tacrolimus
(ASTAGRAF XL)		----1件: 222 💬
183Glutamate and aspartate----1件: 13 💬
184Hearing assessment----1件: 122 💬
185HM71224 multiple ascending dose----1件: 46 💬
186HM71224 single ascending dose----1件: 46 💬
187Human albumin AS macroaggregates1件: Albumin human2件: Albumin human ,
Human serum albumin 💬 		--1件: 96 💬
188Human immunoglobulin G
(ASCENIV)		1件: Human immunoglobulin G1件: Globulin, immune (ASCENIV) 💬 --3件: 14, 50, 63 💬
189Humira - 40MG/0.8ML soluz. iniettabile- USO sottocutaneo-flaconcino(vetro) 0.8ML 2 astucci:1 flaconcino+1siringa+1AGO+1adatt.sterile-2tamponi imbevuti alcool1件: Adalimumab1件: Adalimumab 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 46, 96 💬
190ICG-guided bowel perfusion assessment----1件: 96 💬
191Identical tacrolimus-free lipid suspension FOR enema
(ASTAGRAF XL)		1件: Tacrolimus2件: Tacrolimus (ASTAGRAF XL),
Tacrolimus 💬 		5件: PPP3C,
PPP3C,
PPP3C,
PPP3R,
PPP3R 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 97 💬
192IMP will BE labeled AS PF-04236921 106MG/vial, clonal SC lyophilized form----1件: 96 💬
193IN vitro stimulation OF blood with periodontitis-associated- and control bacteria----1件: 46 💬
194Information collected AS standard OF care----1件: 46 💬
195Injections upper aspect OF trigone OF urinary bladder----1件: 226 💬
196Insulin asparte----1件: 299 💬
197Interlaminar ultrasound-assisted intrathecal administration OF nusinersen----1件: 3 💬
198Intraarticular morphine
(Astramor PH)		----1件: 46 💬
199Laboratory assessment: calcium----3件: 3, 15, 256 💬
200Laboratory assessment: creatine kinase----3件: 3, 15, 256 💬
201Laboratory assessment: magnesium----3件: 3, 15, 256 💬
202Laboratory assessment: phosphate----3件: 3, 15, 256 💬
203Laboratory assessment: vitamin D level----3件: 3, 15, 256 💬
204Laboratory assessments----1件: 85 💬
205Lithium aspartate----1件: 6 💬
206Magnesium aspartate hydrochloride3件: Magnesium,
Magnesium aspartate (Magnesium aspartate),
Magnesium aspartate hydrochloride (Magnesium aspartate hydrochloride)		1件: Magnesium L-aspartate (Magnesium L-aspartate, Magnesium aspartate) 💬 --1件: 298 💬
207Mesalamine, 5-ASA1件: Mesalazine (5-ASA)1件: Mesalamine (Asacol) 💬 --1件: 97 💬
208Mesalazine
(Asacol)		1件: Mesalazine (5-ASA)1件: Mesalamine (Asacol) 💬 --3件: 46, 96, 97 💬
209Mesalazine - TID 1000 MG
(Asacol)		1件: Mesalazine (5-ASA)1件: Mesalamine (Asacol) 💬 --1件: 97 💬
210Mesalazine - TID 2X 500 MG
(Asacol)		1件: Mesalazine (5-ASA)1件: Mesalamine (Asacol) 💬 --1件: 97 💬
211Mesalazine 1000 MG gastro-resistant tablets
(Asacol)		1件: Mesalazine (5-ASA)1件: Mesalamine (Asacol) 💬 --1件: 97 💬
212Mesalazine 250MG tablet and nitazoxanide 500MG oral tablet
(Asacol)		1件: Mesalazine (5-ASA)1件: Mesalamine (Asacol) 💬 --1件: 97 💬
213Mesalazine 4G enema
(Asacol)		1件: Mesalazine (5-ASA)1件: Mesalamine (Asacol) 💬 --1件: 97 💬
214Mesalazine 500 MG gastro-resistant tablets (salofa
(Asacol)		1件: Mesalazine (5-ASA)1件: Mesalamine (Asacol) 💬 --1件: 97 💬
215Mesalazine EC 500 MG
(Asacol)		1件: Mesalazine (5-ASA)1件: Mesalamine (Asacol) 💬 --1件: 96 💬
216Mesalazine enema
(Asacol)		1件: Mesalazine (5-ASA)1件: Mesalamine (Asacol) 💬 --1件: 97 💬
217Mesalazine liquid enema
(Asacol)		1件: Mesalazine (5-ASA)1件: Mesalamine (Asacol) 💬 --1件: 97 💬
218Mesalazine SLOW-release granules
(Asacol)		1件: Mesalazine (5-ASA)1件: Mesalamine (Asacol) 💬 --1件: 97 💬
219Mesalazine suppository treatment
(Asacol)		1件: Mesalazine (5-ASA)1件: Mesalamine (Asacol) 💬 --1件: 97 💬
220Mesalazine sustained-release tablets
(Asacol)		1件: Mesalazine (5-ASA)1件: Mesalamine (Asacol) 💬 --1件: 96 💬
221Mesalazine tablets
(Asacol)		1件: Mesalazine (5-ASA)1件: Mesalamine (Asacol) 💬 --1件: 96 💬
222Mesalazine with hydrocortisone sodium succinate
(Asacol)		2件: Hydrocortisone,
Mesalazine (5-ASA)		2件: Hydrocortisone ,
Mesalamine (Asacol) 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 97 💬
223Mesalazine, tripterygium glycosides
(Asacol)		1件: Mesalazine (5-ASA)1件: Mesalamine (Asacol) 💬 --1件: 96 💬
224Methotrexate AS methotrexate disodium1件: Methotrexate2件: Methotrexate ,
Methotrexate sodium 💬 		2件: DHFR,
DHFR 💬 		3件: Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬1件: 46 💬
225MMX mesalamine/ mesalazine
(Asacol)		----1件: 97 💬
226MMX mesalamine/mesalazine
(Asacol)		1件: Mesalazine (5-ASA)1件: Mesalamine (Asacol) 💬 --1件: 97 💬
227Mometasone furoate
(Asmanex, ASMANEX, ASMANEX HFA)		2件: Mometasone,
Mometasone furoate		3件: Mometasone furoate (Asmanex, ASMANEX, ASMANEX HFA),
Mometasone furoate hydrate ,
Mometasone 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬2件: 98, 162 💬
228Monovalent [B.1.351] COV2 pres DTM-AS03----7件: 13, 35, 46, 49, 50, 51, 107 💬
229Monthly assessments OF functional motor abilities BY A trained therapist----1件: 3 💬
230Morphine
(Astramor PH)		1件: Morphine4件: Morphine sulfate (Astramor PH),
Morphine hydrochloride hydrate ,
Morphine ,
Morphine tartrate 💬 		1件: OPRM1 💬 5件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬2件: 46, 298 💬
231Morphine hexal
(Astramor PH)		1件: Morphine4件: Morphine sulfate (Astramor PH),
Morphine hydrochloride hydrate ,
Morphine ,
Morphine tartrate 💬 		1件: OPRM1 💬 5件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬1件: 46 💬
232Morphine hydrochloride
(Astramor PH)		1件: Morphine4件: Morphine sulfate (Astramor PH),
Morphine hydrochloride hydrate ,
Morphine ,
Morphine tartrate 💬 		1件: OPRM1 💬 5件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬1件: 85 💬
233Morphine PCA
(Astramor PH)		1件: Morphine4件: Morphine sulfate (Astramor PH),
Morphine hydrochloride hydrate ,
Morphine ,
Morphine tartrate 💬 		1件: OPRM1 💬 5件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬1件: 70 💬
234Morphine sulfate
(Astramor PH)		1件: Morphine4件: Morphine sulfate (Astramor PH),
Morphine hydrochloride hydrate ,
Morphine ,
Morphine tartrate 💬 		1件: OPRM1 💬 5件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬3件: 46, 85, 86 💬
235Morphine sulphate IN intrasite GEL
(Astramor PH)		1件: Morphine4件: Morphine sulfate (Astramor PH),
Morphine hydrochloride hydrate ,
Morphine ,
Morphine tartrate 💬 		1件: OPRM1 💬 5件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬1件: 36 💬
236Motor assessment----1件: 6 💬
237Motor assessments before taking regular PD treatment----1件: 6 💬
238Motor assessments ON regular PD treatment----1件: 6 💬
239Motor imagery AS compared TO physical practice FOR balance tasks----1件: 13 💬
240Motor milestone assessments----1件: 113 💬
241Mrna encoding modified ornithine transcarbamylase
(Ornithine aspartate)		----1件: 251 💬
242Multiple ascending doses OF QRL-201----1件: 2 💬
243NEO-ASA----1件: 251 💬
244Neuro-psychological assessment----1件: 240 💬
245Neurocognitive assessment----1件: 6 💬
246Neuropsychological assessment----1件: 127 💬
247Neuropsychological assessments----1件: 34 💬
248NON AS OF YET----1件: 97 💬
249None AS OF YET----1件: 46 💬
250None assigned----2件: 231, 299 💬
251Normal human immunoglobulin G
(ASCENIV)		----1件: 65 💬
252NOT YET assigned----2件: 36, 97 💬
253Novorapid aspartate----1件: 299 💬
254Nutritional assessment----1件: 6 💬
255Observation OF ocrelizumab AS treatment IN rrms patients----1件: 13 💬
256Observational study TO examine safety, tolerability, and effectiveness OF spinraza® prescribed AS part OF standard OF care----1件: 3 💬
257Optional pharmacogenetic assessment----1件: 6 💬
258Oral 5-ASA+/-topical 5-ASA+IV corticosteroids / PO methylprednisolone----1件: 97 💬
259Oral glucose tolerance test (ogtt) assessment ARM----1件: 299 💬
260Ornithine alpha ketoglutarate
(Ornithine aspartate)		1件: Ornithine (Ornithine aspartate)2件: Ornithine ,
Ornithine aspartate (Ornithine aspartate) 💬 		--1件: 245 💬
261Ornithine transcarbamylase vector
(Ornithine aspartate)		1件: Ornithine (Ornithine aspartate)2件: Ornithine ,
Ornithine aspartate (Ornithine aspartate) 💬 		--1件: 251 💬
262Otezla - 10 MG + 20 MG + 30 MG compressa rivestita CON film USO orale - blister (PVC/ALU) IN UN astuccio - 4 compresse DA 10 MG + 4 compresse DA 20 MG +19 compresse DA 30 MG1件: Apremilast1件: Apremilast 💬 4件: PDE4,
PDE4,
PDE4,
PDE4 💬 		4件: Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬2件: 56, 107 💬
263Outer membrane vesicles (OMV) from neisseria meningitidis group B strain NZ98/254measured AS amount OF total protein containing THE pora P1.4----1件: 11 💬
264Overencapsulated mesalazine tablets
(Asacol)		1件: Mesalazine (5-ASA)1件: Mesalamine (Asacol) 💬 --1件: 97 💬
265Participant SELF-assessment surveys----1件: 6 💬
266Periodontitis-associated bacteria presence----1件: 46 💬
267Polidocanol
(Asclera, ASCLERA)		1件: Polidocanol2件: Laureth 4 ,
Polidocanol (Asclera, ASCLERA) 💬 		--3件: 34, 278, 279 💬
268PRE liver transplantation laparoscopic hand assisted staging----1件: 94 💬
269Previously known AS R935788----1件: 46 💬
270Previously referred TO AS MEDI2070 and AMG 139----1件: 97 💬
271Previously referred TO AS MEDI2070 and AMG 139, AGN-151-598----1件: 96 💬
272Procalcitonin-variants elisa-assay1件: Procalcitonin---2件: 43, 44 💬
273Pyridostigmine, prednisone, tacrolimus
(ASTAGRAF XL)		1件: Pyridostigmine1件: Pyridostigmine bromide 💬 1件: ACHE 💬 3件: Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬1件: 11 💬
274Pyridostigmine, tacrolimus
(ASTAGRAF XL)		1件: Pyridostigmine1件: Pyridostigmine bromide 💬 1件: ACHE 💬 3件: Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬1件: 11 💬
275QOL assessment, neuropsychological----1件: 34 💬
276Quality OF life assessment----2件: 81, 122 💬
277Quality-OF-life assessment----11件: 28, 34, 36, 51, 62, 63, 65, 96, 284, 286, 298 💬
278Quantiferon-TB gold assay----1件: 46 💬
279Questionnaires and clinical assessments----1件: 6 💬
280RAAV-OLIG001-aspa1件: MYR-101 (rAAV-Olig001-ASPA)---1件: 307 💬
281RAAV9-CB6-aspa----1件: 307 💬
282Ranolazine
(ASPRUZYO SPRINKLE)		1件: Ranolazine2件: Ranolazine (ASPRUZYO SPRINKLE),
Ranolazine hydrochloride 💬 		--7件: 2, 58, 86, 96, 97, 113, 114 💬
283Ranolazine 1000 MG
(ASPRUZYO SPRINKLE)		1件: Ranolazine2件: Ranolazine (ASPRUZYO SPRINKLE),
Ranolazine hydrochloride 💬 		--1件: 2 💬
284Ranolazine 1000 MG PR tablets
(ASPRUZYO SPRINKLE)		1件: Ranolazine2件: Ranolazine (ASPRUZYO SPRINKLE),
Ranolazine hydrochloride 💬 		--1件: 58 💬
285Ranolazine 500 MG
(ASPRUZYO SPRINKLE)		1件: Ranolazine2件: Ranolazine (ASPRUZYO SPRINKLE),
Ranolazine hydrochloride 💬 		--1件: 2 💬
286Ranolazine 500 MG PR tablets
(ASPRUZYO SPRINKLE)		1件: Ranolazine2件: Ranolazine (ASPRUZYO SPRINKLE),
Ranolazine hydrochloride 💬 		--1件: 58 💬
287Ranolazine 750 MG PR tablets
(ASPRUZYO SPRINKLE)		1件: Ranolazine2件: Ranolazine (ASPRUZYO SPRINKLE),
Ranolazine hydrochloride 💬 		--1件: 58 💬
288Ranolazine PR (prolonged-release) 500 MG 1 tablet BIS IN DIE and 750 MG 1 tablet BIS IN DIE
(ASPRUZYO SPRINKLE)		1件: Ranolazine2件: Ranolazine (ASPRUZYO SPRINKLE),
Ranolazine hydrochloride 💬 		--1件: 58 💬
289Recombinant adeno-associated viral vector expressing THE human alpha-1-antitrypsin gene----1件: 231 💬
290Recombinant adeno-associated viral vector serotype 2.7m8 containing THE chrimsonr-tdtomato gene----1件: 90 💬
291Recombinant adeno-associated virus 2/6 vector encoding THE cdna FOR human alpha galactosidase A----1件: 19 💬
292Recombinant adeno-associated virus acid alpha-glucosidase----1件: 256 💬
293Recombinant adenovirus containing THE ornithine transcarbamylase gene
(Ornithine aspartate)		----1件: 251 💬
294Recombinant human alpha-galactosidase abbreviated AS R-H-alpha-GAL----1件: 19 💬
295Recombinant SELF-complementary adeno-associated viral vector serotype 9 containing THE human CLN6 gene----1件: 19 💬
296Rectal tacrolimus
(ASTAGRAF XL)		----1件: 97 💬
297Response TO anakinra associated with methotrexate----1件: 46 💬
298Response TO infliximab associated with methotrexate----1件: 46 💬
299REX robotic assisted balance exercises----1件: 13 💬
300Rhasa [recombinant human arylsulfatase A], formerly HGT-1110, NOW also known AS TAK-611----1件: 19 💬
301Rituximab combined with tacrolimus induction + rituximab maintenance
(ASTAGRAF XL)		1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 222 💬
302Rituximab combined with tacrolimus induction + tacrolimus maintenance
(ASTAGRAF XL)		1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 222 💬
303Salbutamol (AS salbutamol sulfate) 2 MG oral tablet1件: Albuterol2件: Albuterol sulfate ,
Albuterol 💬 		1件: ADRB2 💬 11件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 111 💬
304Saline AS A nasal spray----1件: 226 💬
305Scale FOR assessment and rating OF ataxia----1件: 113 💬
306Second-line cognitive assessment----1件: 3 💬
307Sildenafil singly or IN association with bosentan1件: Sildenafil2件: Sildenafil citrate ,
Sildenafil 💬 		1件: PDE5 💬 2件: Purine metabolism, cGMP-PKG signaling pathway 💬1件: 86 💬
308SIN asignar----1件: 299 💬
309Sleep assessment----1件: 13 💬
310Slit lamp assessment and intra-ocular pressure measurement----1件: 19 💬
311Smoking and alcohol assumption----1件: 298 💬
312Sodium ascorbate2件: Ascorbic acid (Ascorbate),
Sodium ascorbate (sodium L-ascorbate)		2件: Ascorbic acid (Ascorbic acid, Ascoltin, Ascorbicap, ASCOR, ASCOR),
Sodium ascorbate (Sodium ascorbate) 💬 		--1件: 97 💬
313Somatotropin
(Asellacrin)		1件: Somatotropin1件: Somatropin (Asellacrin) 💬 1件: GHR 💬 6件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬2件: 3, 65 💬
314SPD476 IS A polymeric matrix formulation that displays both delayed- and extended-release OF mesalazine
(Asacol)		1件: Mesalazine (5-ASA)1件: Mesalamine (Asacol) 💬 --1件: 97 💬
315STK-001 - multiple ascending doses1件: Zorevunersen---1件: 140 💬
316STK-001 - single ascending doses1件: Zorevunersen---1件: 140 💬
317Subretinal administration OF RAAV2-VMD2-hmertkrecombinant adeno-associated virus----1件: 90 💬
318Sudoscan and clinical assessment----1件: 6 💬
319Sulphsalazine, pentasa, asacol, colazide, depentum----1件: 97 💬
320Tacrolimus
(ASTAGRAF XL)		1件: Tacrolimus2件: Tacrolimus (ASTAGRAF XL),
Tacrolimus 💬 		5件: PPP3C,
PPP3C,
PPP3C,
PPP3R,
PPP3R 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬31件: 2, 6, 11, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 234, 283, 284, 285, 286 💬
321Tacrolimus and MMF
(ASTAGRAF XL)		1件: Tacrolimus2件: Tacrolimus (ASTAGRAF XL),
Tacrolimus 💬 		5件: PPP3C,
PPP3C,
PPP3C,
PPP3R,
PPP3R 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 299 💬
322Tacrolimus capsule
(ASTAGRAF XL)		1件: Tacrolimus2件: Tacrolimus (ASTAGRAF XL),
Tacrolimus 💬 		5件: PPP3C,
PPP3C,
PPP3C,
PPP3R,
PPP3R 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 11 💬
323Tacrolimus capsules
(ASTAGRAF XL)		1件: Tacrolimus2件: Tacrolimus (ASTAGRAF XL),
Tacrolimus 💬 		5件: PPP3C,
PPP3C,
PPP3C,
PPP3R,
PPP3R 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬2件: 222, 299 💬
324Tacrolimus combined with prednisone
(ASTAGRAF XL)		1件: Tacrolimus2件: Tacrolimus (ASTAGRAF XL),
Tacrolimus 💬 		5件: PPP3C,
PPP3C,
PPP3C,
PPP3R,
PPP3R 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 222 💬
325Tacrolimus FOR THE treatment OF IMN
(ASTAGRAF XL)		1件: Tacrolimus2件: Tacrolimus (ASTAGRAF XL),
Tacrolimus 💬 		5件: PPP3C,
PPP3C,
PPP3C,
PPP3R,
PPP3R 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 222 💬
326Tacrolimus lipid suspension FOR enema
(ASTAGRAF XL)		1件: Tacrolimus2件: Tacrolimus (ASTAGRAF XL),
Tacrolimus 💬 		5件: PPP3C,
PPP3C,
PPP3C,
PPP3R,
PPP3R 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 97 💬
327Tacrolimus ointment
(ASTAGRAF XL)		1件: Tacrolimus2件: Tacrolimus (ASTAGRAF XL),
Tacrolimus 💬 		5件: PPP3C,
PPP3C,
PPP3C,
PPP3R,
PPP3R 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 56 💬
328Tacrolimus prolonged-release hard capsules
(ASTAGRAF XL)		1件: Tacrolimus2件: Tacrolimus (ASTAGRAF XL),
Tacrolimus 💬 		5件: PPP3C,
PPP3C,
PPP3C,
PPP3R,
PPP3R 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 299 💬
329Tacrolimus with methotrexate
(ASTAGRAF XL)		1件: Tacrolimus2件: Tacrolimus (ASTAGRAF XL),
Tacrolimus 💬 		5件: PPP3C,
PPP3C,
PPP3C,
PPP3R,
PPP3R 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 46 💬
330Terbutaline
(Asthmasian)		1件: Terbutaline2件: Terbutaline sulfate ,
Terbutaline (Asthmasian) 💬 		1件: ADRB2 💬 11件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 118 💬
331THE investigational medicinal product (IMP) will BE labeled AS PF-04236921 106 MG/vial, clonal SC lyophilized form, which IS equivalent TO PF-04236921 powder FOR injection, 106 MG/vial AS described IN THE enclosed CTA----1件: 96 💬
332Theophylline
(Asbron)		1件: Theophylline3件: Theophylline ,
Theophylline ,
Theophylline sodium glycinate (Asbron) 💬 		18件: ADORA1,
ADORA2B,
PDE1,
PDE1,
PDE1,
PDE10,
PDE11,
PDE2A,
PDE3A,
PDE3B,
PDE4,
PDE4,
PDE4,
PDE4,
PDE7,
PDE7,
PDE8,
PDE8 💬 		23件: Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Cortisol synthesis and secretion, Cushing syndrome, Glucagon signaling pathway, Insulin signaling pathway, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬2件: 236, 299 💬
333Theophylline ER
(Asbron)		1件: Theophylline3件: Theophylline ,
Theophylline ,
Theophylline sodium glycinate (Asbron) 💬 		18件: ADORA1,
ADORA2B,
PDE1,
PDE1,
PDE1,
PDE10,
PDE11,
PDE2A,
PDE3A,
PDE3B,
PDE4,
PDE4,
PDE4,
PDE4,
PDE7,
PDE7,
PDE8,
PDE8 💬 		23件: Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Cortisol synthesis and secretion, Cushing syndrome, Glucagon signaling pathway, Insulin signaling pathway, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 236 💬
334Tildrakizumab
(Tildrakizumab-asmn)		1件: Tildrakizumab1件: Tildrakizumab (Tildrakizumab-asmn) 💬 1件: IL23A 💬 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬1件: 271 💬
335Tildrakizumab 100 MG/ML
(Tildrakizumab-asmn)		1件: Tildrakizumab1件: Tildrakizumab (Tildrakizumab-asmn) 💬 1件: IL23A 💬 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬1件: 271 💬
336Tildrakizumab prefilled syringe
(Tildrakizumab-asmn)		1件: Tildrakizumab1件: Tildrakizumab (Tildrakizumab-asmn) 💬 1件: IL23A 💬 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬1件: 162 💬
337Ultrasonographic assessment OF cervical multifidus and longus colli muscle thickness, postural balance and limit OF stability using THE balance platform,cervical flexion and extension strength----1件: 271 💬
338Ultrasonography assessment----1件: 49 💬
339Ultrasound SUB-study OF assessment OF appendage muscles using ultrasound----1件: 299 💬
340Urinary levels OF piiinp AS A marker OF changes IN renal function----1件: 299 💬
341USE OF bioanalytical assay TO monitor plasma levels OF perhexiline1件: Perhexiline2件: Perhexiline maleate ,
Perhexiline 💬 		8件: CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S,
CPT1A,
CPT1B,
CPT1C,
CPT2 💬 		47件: AMPK signaling pathway, Adipocytokine signaling pathway, Adrenergic signaling in cardiomyocytes, Alcoholic liver disease, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Dilated cardiomyopathy, Dopaminergic synapse, Efferocytosis, Fatty acid degradation, GABAergic synapse, Glucagon signaling pathway, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin resistance, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, PPAR signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Thermogenesis, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 58 💬
342Vasculopathy assessment----1件: 51 💬
343Ventilatory/ respiratory and other support assessment----1件: 113 💬
344Vestibular/balance assessment----1件: 122 💬
345VR040/aspirair® inhaler----1件: 6 💬